Australia markets closed

Arcturus Therapeutics Holdings Inc. (ARCT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
38.81+0.33 (+0.86%)
At close: 04:00PM EDT
39.61 +0.80 (+2.06%)
After hours: 06:10PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-107,296
-29,725
9,349
-203,674
-72,148
-
Depreciation & amortisation
3,283
2,957
1,527
1,193
882
-
Stock-based compensation
36,555
34,649
30,611
28,915
6,764
-
Change in working capital
79,690
7,381
-12,557
32,625
21,216
-
Accounts receivable
65,426
-29,300
603
-1,242
54
-
Accounts payable
-10,161
-2,238
-3,112
-769
4,812
-
Other working capital
9,765
-21,000
24,267
-138,449
-44,603
-
Other non-cash items
-
502
2,173
6,990
162
-
Net cash provided by operating activities
12,215
-18,099
31,993
-135,043
-42,861
-
Cash flows from investing activities
Investments in property, plant and equipment
-2,450
-2,901
-7,726
-3,406
-1,742
-
Purchases of investments
-
-
-
-
0
0
Sales/maturities of investments
-
-
-
-
0
0
Net cash used for investing activities
-2,450
-2,901
-7,726
-3,406
-1,742
-
Cash flows from financing activities
Debt repayment
-20,000
-47,364
-5,000
0
-
-
Common stock issued
-
609
411
515
423,819
-
Net cash used provided by (used for) financing activities
5,465
-24,087
-2,859
48,016
436,145
-
Net change in cash
15,230
-45,087
21,408
-90,433
391,542
-
Cash at beginning of period
330,051
393,977
372,569
463,002
71,460
-
Cash at end of period
345,281
348,890
393,977
372,569
463,002
-
Free cash flow
Operating cash flow
12,215
-18,099
31,993
-135,043
-42,861
-
Capital expenditure
-2,450
-2,901
-7,726
-3,406
-1,742
-
Free cash flow
9,765
-21,000
24,267
-138,449
-44,603
-